|

Low Dose PD-1 mRNA LNP Vaccine Clinical Trials

1 actively recruiting trial

Also known as: PD-1 mRNA LNP vaccine at 50 mcg

Pipeline

Phase 1/2: 1

Top Sponsors

  • West China Hospital1

Indications

  • Liver Disease1
  • Liver Cancer1
  • Cancer1

Other1 trial

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.